Effect of CYP2C9 and VKORC1 genetic variations on warfarin dose requirements in Indian patients.

Journal Title: Pharmacological Reports - Year 2013, Vol 65, Issue 5

Abstract

Background: Warfarin, an oral anticoagulant is used in patients who are at increased risk of developing blood clots. The management of warfarin therapy is challenging because it shows large inter and intra individual variability in patient response due to factors like age, gender, diet, concurrent drug interactions and variations in CYP2C9 and VKORC1 genes. Studies implicate that polymorphisms in VKORC1 and CYP2C9 genes are associated with reduced doses of warfarin. The aim of our current study was to characterize the effects of VKORC1 and CYP2C9 gene variations that contribute to variability in warfarin dosing in Indian patients. Methods: Genomic DNA was extracted from 103 patients undergoing warfarin therapy. Their mean daily warfarin dose, INR and demographics were recorded and genotyping of VKORC1 and CYP2C9 gene was performed by PCR-RFLP method. Results: Individuals with wild type genotypes required highest mean warfarin dosage of 4.72 mg/day while VKORC1 variants required 3.6 mg/day to maintain their therapeutic INR. CYP2C9*2 genotype was not found to affect the warfarin maintenance dosages. The odds ratio for developing supra therapeutic INR in patients carrying VKORC1 variant allele when compared to wild types was 13.96 (95% CI; 4.85 - 44.65. Other factors affecting warfarin dosages were age and weight. Conclusion: Inclusion of pharmacogenetic data along with clinical parameters would help better predict warfarin doses in Indian patients.

Authors and Affiliations

Sripriya Natarajan, Chandrashekhar Ponde, Rajesh Rajani, Farah Jijina, Roopkumar Gursahani, Pradnya Dhairyawan, Tester Ashavaid

Keywords

Related Articles

Pharmacoepigenetics: a new approach to predicting individual drug responses and targeting new drugs.

Epigenetics is the study of heritable changes in genes and gene expression that do not involve DNA nucleotide sequences. Epigenetic modifications include DNA methylation, several forms of histone modifications, and micro...

Platelet interaction with progenitor cells: vascular regeneration or inquiry?

Increasing evidence supports the role of stem and progenitor cells in vascular regeneration or injury. Following tissue ischemia, progenitor cells are mobilized from their bone marrow or peripheral niches into circulatio...

Lack of effect of sildenafil on cocaine-induced convulsions in mice.

The convulsant action of cocaine and the proconvulsant effects of sildenafil, a drug which is widely used in the treatment of erectile dysfunction, have been documented both in humans and mice. Since it was reported that...

Relationship of chemical structure and anti-inflammatory activity of dihydrocorynantheol and its analogues.

Background: Dihydrocorynantheol (DHC) is an alkaloid compound isolated from Esenbeckia leiocarpa Engl. that has demonstrated anti-inflammatory properties in experimental models. The aim of this study was to investigate w...

Statin-induced myopathies.

Statins are considered to be safe, well tolerated and the most efficient drugs for the treatment of hypercholesterolemia, one of the main risk factor for atherosclerosis, and therefore they are frequently prescribed medi...

Download PDF file
  • EP ID EP131275
  • DOI -
  • Views 56
  • Downloads 0

How To Cite

Sripriya Natarajan, Chandrashekhar Ponde, Rajesh Rajani, Farah Jijina, Roopkumar Gursahani, Pradnya Dhairyawan, Tester Ashavaid (2013). Effect of CYP2C9 and VKORC1 genetic variations on warfarin dose requirements in Indian patients.. Pharmacological Reports, 65(5), 1375-1382. https://europub.co.uk/articles/-A-131275